Phylonix Pharmaceuticals, Inc.
100 Inman Street
Suite 300
Cambridge
Massachusetts
02139
United States
Tel: 617-441-6700
Fax: 617-441-6766
7 articles about Phylonix Pharmaceuticals, Inc.
-
National Institutes of Health (NIH) Grants Phylonix Phase II SBIR to Develop High-Throughput In Vivo Zebrafish Assays for Assessing Cytochrome P450 Drug Metabolism and Safety
1/7/2009
-
Phylonix Pharmaceuticals, Inc. Granted Broad European Patent for Transplanting Human Cells Into Zebrafish
12/18/2007
-
Phylonix Pharmaceuticals, Inc. Release: National Institutes of Health (NIH) Awards Phylonix Phase II SBIR to Develop Zebrafish Models for Eye Diseases
10/2/2007
-
EPA Selects Phylonix Pharmaceuticals, Inc. to Screen Compound Library in Zebrafish
4/12/2007
-
Phylonix Pharmaceuticals, Inc. Awarded National Science Foundation Phase II SBIR To Screen Industrial Chemicals For Effects On Developmental Toxicity In Zebrafish
12/12/2006
-
Phylonix Pharmaceuticals, Inc. Release: Zebrafish Show Advantages In Assessing Human Cancer Cell-Induced Angiogenesis In Vivo
8/8/2006
-
Phylonix Pharmaceuticals, Inc. Issued Broad U.S. Patent For Screening Angiogenic Compounds Using Zebrafish
5/10/2006